Flipped Autograft for Treating Surgical Wound Dehiscence

Wound Dehiscence Clinical Trial

Official title:

Flipped Autograft: a Novel Approach for Management of Wound Dehiscence in Implant Dentistry

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05513222
• Other study ID #: hamdy
• Status: Completed
• Phase: N/A
• Start date: July 22, 2021
• Est. completion date: April 27, 2022

Study information

• Verified date: March 2024
• Source: Ain Shams University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This case report describes a novel technique for management of peri-implant wound dehiscence that involves using auto graft from the same surgical site to seal the dehiscence defect.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 10
• Est. completion date: April 27, 2022
• Est. primary completion date: January 29, 2022
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

1. Adult patients in a healthy systemic condition.

2. Both genders

3. Patients should have single missing tooth.

4. Seibert Class I ridge defect.

5. Patients should approve to deliver a signature to a written consent after study nature explanation.

Exclusion Criteria:

• 1- Patients with any smoking habits. 2- Pregnant females, decisional impaired individuals, Prisoners and handicapped patients.

3- Patients having poor oral hygiene or not wanting to carry out oral hygiene measures.

4- Patients with infections either periodontally or periapically.

Related Conditions & MeSH terms

• Wound Dehiscence
• Wounds and Injuries

Intervention

Procedure:
• flipped autograft
Thick lingual flap was de-epithelized and partially dissected to increase its length then flipped and sutured to the buccal flap to obtain primary closure

Locations

Country	Name	City	State
Egypt	Ahmed Hamdy	Cairo

Sponsors (2)

Lead Sponsor	Collaborator
Ain Shams University	British University In Egypt

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	complete primary intention healing of the wound dehiscence	complete uneventful healing will be assessed clinically by measuring soft tissue width and thickness using periodontal probe under local anesthesia	3 months
Secondary	esthetic outcome and patient satisfaction.	esthetic outcome will be measured using pink esthetic score. Pink esthetic score (PES) will be recorded for five variables: "mesial papilla, distal papilla, curvature of the facial mucosa, level of the facial mucosa, and root convexity/soft tissue color and texture at the facial aspect of the implant site". A score of 2, 1, or 0 will be assigned to all five parameters.; also patient satisfaction will be recorded using: • (VAS) Visual analogue scale to measure postoperative pain. Pain score reported by the patient. directly through Visual Analogue Scale score (from 0 to 10. 0: no pain, 1: minimal pain, 5: moderate pain, 10: severe pain) which will be recorded after 2 weeks (Yildirim et al., 2017)	3 months